Shared IVIVR for Five Commercial Enabling Formulations Using the BiPHa+ Biphasic Dissolution Assay

The present study intended to confirm the in vivo relevance of the BiPHa+ biphasic dissolution assay using a single set of assay parameters. Herein, we evaluated five commercial drug products formulated by various enabling formulation principles under fasted conditions using the BiPHa+ assay. The in...

Descripción completa

Detalles Bibliográficos
Autores principales: Denninger, Alexander, Westedt, Ulrich, Wagner, Karl G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927064/
https://www.ncbi.nlm.nih.gov/pubmed/33671597
http://dx.doi.org/10.3390/pharmaceutics13020285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927064/
https://www.ncbi.nlm.nih.gov/pubmed/33671597
http://dx.doi.org/10.3390/pharmaceutics13020285

Ejemplares similares